CureVac N.V (CVAC) Social Stream



CureVac N.V (CVAC): $11.68

-0.11 (-0.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CVAC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

CUREVAC NV (CVAC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CVAC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 3 $65 $41 $53 $11.79 349.53%
2022-01-05 3 $55 $41 $48 $11.79 307.12%
2022-01-18 4 $55 $41 $49.333 $11.79 318.43%
2022-04-11 4 $52 $20 $37.666 $11.79 219.47%
2022-05-09 3 $52 $17 $29.666 $11.79 151.62%
2022-05-27 3 $52 $17 $29.333 $11.79 148.8%
2022-08-13 3 $52 $15 $28.666 $11.79 143.14%
2022-08-19 3 $52 $15 $28.333 $11.79 140.31%
2022-09-17 3 $52 $13 $27.666 $11.79 134.66%
2022-11-17 3 $34.001 $13 $21.667 $11.79 83.77%
2022-11-18 3 $34.001 $10 $19 $11.79 61.15%
2023-01-06 3 $34.001 $9 $17.667 $11.79 49.85%
2023-01-27 3 $34.001 $10 $21.667 $11.79 83.77%

The Trend in the Analyst Price Target


Over the past 16 months, CVAC's average price target has gone down $49.71.

Over the past 42 weeks, CVAC's average upside potential has been 126.95%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-11 3 52.000 20 37.666 17.27 118.1%
2022-05-27 3 52.000 17 29.333 19.35 51.59%
2022-09-17 3 52.000 13 27.666 9.57 189.09%
2022-11-21 3 34.001 9 17.667 7.95 122.23%
2023-01-04 3 34.001 9 17.667 6.58 168.5%

CVAC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 2 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 35 weeks, CVAC's average broker recommendation rating improved by 0.67.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, CUREVAC NV's number of analysts covering the stock is higher than 154.11% of them.
  • In terms of how CUREVAC NV fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 1375.2% of that group.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, CUREVAC NV's variance in analysts' estimates is lower than -1031.32% of them.
  • In terms of how CUREVAC NV fares relative to stocks in the large market cap category, note that its average analyst price target is greater than 267.26% of that group.

Stocks similar to CUREVAC NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MRVI, ABCL, and RVMD.

Is CVAC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5702 seconds.